The Biotech Growth Trust (LON:BIOG) Share Price Passes Below 50 Day Moving Average – Here’s Why

The Biotech Growth Trust PLC (LON:BIOGGet Free Report) crossed below its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of GBX 843.02 ($10.92) and traded as low as GBX 762.43 ($9.88). The Biotech Growth Trust shares last traded at GBX 763 ($9.88), with a volume of 89,042 shares trading hands.

The Biotech Growth Trust Stock Performance

The company has a current ratio of 0.59, a quick ratio of 0.00 and a debt-to-equity ratio of 11.02. The stock’s fifty day simple moving average is GBX 843.02 and its 200 day simple moving average is GBX 933.52. The company has a market cap of £217.98 million, a price-to-earnings ratio of 2.56 and a beta of 0.50.

Insider Activity

In other news, insider Nicola Shepherd acquired 1,000 shares of the company’s stock in a transaction that occurred on Monday, January 13th. The stock was purchased at an average price of GBX 846 ($10.96) per share, with a total value of £8,460 ($10,958.55). Also, insider Hamish Baillie bought 1,200 shares of The Biotech Growth Trust stock in a transaction on Thursday, December 19th. The shares were purchased at an average cost of GBX 856 ($11.09) per share, for a total transaction of £10,272 ($13,305.70). Company insiders own 0.71% of the company’s stock.

The Biotech Growth Trust Company Profile

(Get Free Report)

The Biotech Growth Trust seeks capital appreciation through investment in the worldwide biotechnology industry. In order to achieve its investment objective, the Company invests in a diversified portfolio of shares and related securities in biotechnology companies on a worldwide basis. Performance is measured against the NASDAQ Biotechnology Index (sterling adjusted).

Featured Stories

Receive News & Ratings for The Biotech Growth Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Biotech Growth Trust and related companies with MarketBeat.com's FREE daily email newsletter.